FAKTOR-OPTIONSSCHEIN - IPSEN | Real-time Bid/Ask 09:17:37 2024-07-11 am EDT | ||
| 8.75 EUR / 8.8 EUR | -4.52% |
|
| Current month | +14.02% | ||
| 1 month | +37.16% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
More news
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 8.8 | -4.24% |
| 24-07-10 | 9.19 | +0.33% |
| 24-07-09 | 9.16 | +1.44% |
| 24-07-08 | 9.03 | +3.08% |
| 24-07-05 | 8.76 | +8.96% |
Delayed Quote Börse Stuttgart
Last update July 11, 2024 at 09:02 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Morgan Stanley |
| WKN | MG1K9W |
| ISIN | DE000MG1K9W8 |
| Date issued | 2024-04-03 |
| Strike | 145.6 € |
| Maturity | Unlimited |
| Parity | 3.94 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.49 € |
|---|---|
| Lowest since issue | 6.19 € |
| Spread | 0.05 € |
| Spread % | 0.57% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
109.2
EUR
Average target price
127.3
EUR
Spread / Average Target
+16.55%
- Stock Market
- Certificates
- Certificat
